Announcement on Reply to Letter of Supervision and Inquiry from Shanghai Stock Exchange on Information Disclosure of 2024 Annual Report

About this update from Zhejiang Huakang Pharmaceutical Co., Ltd. Class A

Announcement on Reply to Letter of Supervision and Inquiry from Shanghai Stock Exchange on Information Disclosure of 2024 Annual ReportThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Huakang Pharmaceutical Co., Ltd. Class A